Compound E, chemically designated as the compound 209986-17-4, represents a significant study within the field of Alzheimer's illness research. This γ-secretase inhibitor was initially developed as a possible https://alyssadcmk484022.activoblog.com/51134816/γ-secretase-inhibitor-compound-e-209986-17-4